KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Enterprise Value (2016 - 2025)

Resmed (RMD) has disclosed Enterprise Value for 17 consecutive years, with -$1.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 171.5% year-over-year to -$1.4 billion, compared with a TTM value of -$1.4 billion through Dec 2025, down 171.5%, and an annual FY2025 reading of -$1.2 billion, down 407.4% over the prior year.
  • Enterprise Value was -$1.4 billion for Q4 2025 at Resmed, down from -$1.4 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$194.5 million in Q4 2021 and bottomed at -$1.4 billion in Q4 2025.
  • Average Enterprise Value over 5 years is -$458.8 million, with a median of -$245.8 million recorded in 2022.
  • The sharpest move saw Enterprise Value soared 36.25% in 2021, then crashed 407.4% in 2025.
  • Year by year, Enterprise Value stood at -$194.5 million in 2021, then crashed by 30.2% to -$253.2 million in 2022, then rose by 16.96% to -$210.2 million in 2023, then crashed by 148.25% to -$521.9 million in 2024, then plummeted by 171.5% to -$1.4 billion in 2025.
  • Business Quant data shows Enterprise Value for RMD at -$1.4 billion in Q4 2025, -$1.4 billion in Q3 2025, and -$1.2 billion in Q2 2025.